Novel Assay for Assessing ROS

Information

  • Research Project
  • 7676616
  • ApplicationId
    7676616
  • Core Project Number
    R43GM087923
  • Full Project Number
    1R43GM087923-01
  • Serial Number
    87923
  • FOA Number
    PA-08-050
  • Sub Project Id
  • Project Start Date
    7/1/2009 - 15 years ago
  • Project End Date
    2/28/2011 - 13 years ago
  • Program Officer Name
    SOMERS, SCOTT D.
  • Budget Start Date
    7/1/2009 - 15 years ago
  • Budget End Date
    2/28/2011 - 13 years ago
  • Fiscal Year
    2009
  • Support Year
    1
  • Suffix
  • Award Notice Date
    6/22/2009 - 15 years ago

Novel Assay for Assessing ROS

DESCRIPTION (provided by applicant): Reactive oxygen species (ROS) are known to contribute as pathogenic factors to the development of chronic progressive diseases at various stages. ROS are also involved in a variety of different cellular processes ranging from apoptosis and necrosis to cell proliferation and carcinogenesis. ROS are well recognized for playing a dual role as both deleterious and beneficial species. They are also capable of inducing DNA damage that eventually may contribute to cell transformation and tumor initiation and are also associated with tumor promotion and progression. ROS also act as primary or secondary messengers to promote cell growth or death. In Phase I research, we will develop a microplate-based zebrafish whole animal assay to assess drug-induced oxidative stress. PUBLIC HEALTH RELEVANCE: Molecular players comprise both reactive oxygen (ROS) and reactive nitrogen species (RNS), which are known to contribute as pathogenic factors to the development of chronic progressive diseases at various stages.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    193979
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:193979\
  • Funding Mechanism
    SBIR-STTR
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    PHYLONIX PHARMACEUTICALS, INC.
  • Organization Department
  • Organization DUNS
    071479849
  • Organization City
    CAMBRIDGE
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    02139
  • Organization District
    UNITED STATES